-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PLN-101095 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PLN-101095 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PLN-101095 in Solid Tumor Drug Details: PLN-101095 is under development for...
-
Product Insights
NewNet Present Value Model: Pliant Therapeutics Inc’s PLN-74809
Empower your strategies with our Net Present Value Model: Pliant Therapeutics Inc's PLN-74809 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexotegrast in Idiopathic Pulmonary Fibrosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Bexotegrast in Idiopathic Pulmonary Fibrosis Drug Details: Bexotegrast (PLN-74809) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PLN-1474 in Liver Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PLN-1474 in Liver Fibrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PLN-1474 in Liver Fibrosis Drug Details: PLN-1474 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PLN-1474 in Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PLN-1474 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PLN-1474 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Drug Details: PLN-1474 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EDP-323 in Respiratory Syncytial Virus (RSV) Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EDP-323 in Respiratory Syncytial Virus (RSV) Infections report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EDP-323 in Respiratory Syncytial Virus (RSV) Infections Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GFH-009 in Diffuse Large B-Cell Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GFH-009 in Diffuse Large B-Cell Lymphoma Drug Details: GFH-009 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ABBVCLS-7262 in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ABBVCLS-7262 in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ABBVCLS-7262 in Amyotrophic Lateral Sclerosis Drug Details: ABBVCLS-7262 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tipelukast in Hypertriglyceridemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tipelukast in Hypertriglyceridemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tipelukast in Hypertriglyceridemia Drug Details: Tipelukast (KCA-757) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bexotegrast in Primary Sclerosing Cholangitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bexotegrast in Primary Sclerosing Cholangitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bexotegrast in Primary Sclerosing Cholangitis Drug Details: Bexotegrast (PLN-74809) is under...